TP53 Mutations and Other Cell-Intrinsic Determinants of the Apoptotic Response to Ibrutinib in Chronic Lymphocytic Leukemia

被引：0
|
作者：
Amin, Nisar A. [1 ]
Balasubramanian, Sriram [2 ]
Saiya-Cork, Kamlai [1 ]
Malek, Sami N. [3 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Janssen Res & Dev, Spring House, PA USA
[3] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations
    Ahn, Inhye E.
    Tian, Xin
    Wiestner, Adrian
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05): : 498 - 500
  • [2] Cell-Intrinsic Determinants of Ibrutinib-Induced Apoptosis in Chronic Lymphocytic Leukemia
    Amin, Nisar A.
    Balasubramanian, Sriram
    Saiya-Cork, Kamlai
    Shedden, Kerby
    Hu, Nan
    Malek, Sami N.
    CLINICAL CANCER RESEARCH, 2017, 23 (04) : 1049 - 1059
  • [3] TP53 Disruption in Chronic Lymphocytic Leukemia Under Ibrutinib: More is Worse?
    Bomben, Riccardo
    Zucchetto, Antonella
    Gentile, Massimo
    Gattei, Valter
    CLINICAL CANCER RESEARCH, 2021, 27 (16) : 4462 - 4464
  • [4] The TP53 Codon72 Polymorphism Is Associated with TP53 Mutations in Chronic Lymphocytic Leukemia
    Grossmann, Vera
    Artusi, Valentina
    Schnittger, Susanne
    Dicker, Frank
    Jeromin, Sabine
    Boeck, Lucia
    Haferlach, Torsten
    Haferlach, Claudia
    Kern, Wolfgang
    Kohlmann, Alexander
    BLOOD, 2011, 118 (21) : 778 - 778
  • [5] Selection of new TP53 mutations by therapy in chronic lymphocytic leukemia
    Trbusek, Martin
    Malcikova, Jitka
    Mayer, Jiri
    LEUKEMIA RESEARCH, 2011, 35 (07) : 981 - 982
  • [6] TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia
    Zainuddin, Norafiza
    Murray, Fiona
    Kanduri, Meena
    Gunnarsson, Rebeqa
    Smedby, Karin E.
    Enblad, Gunilla
    Jurlander, Jesper
    Juliusson, Gunnar
    Rosenquist, Richard
    LEUKEMIA RESEARCH, 2011, 35 (02) : 272 - 274
  • [7] Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia
    Cafforio, Luciana
    Raponi, Sara
    Cappelli, Luca Vincenzo
    Ilari, Caterina
    Soscia, Roberta
    De Propris, Maria Stefania
    Mariglia, Paola
    Rigolin, Gian Matteo
    Bardi, Antonella
    Peragine, Nadia
    Piciocchi, Alfonso
    Arena, Valentina
    Mauro, Francesca Romana
    Cuneo, Antonio
    Guarini, Anna
    Foa, Robin
    Del Giudice, Ilaria
    HAEMATOLOGICA, 2022, 107 (01) : 334 - 337
  • [8] TP53 Aberrations in Chronic Lymphocytic Leukemia
    Trbusek, Martin
    Malcikova, Jitka
    ADVANCES IN CHRONIC LYMPHOCYTIC LEUKEMIA, 2013, 792 : 109 - 131
  • [9] Clinical Impact of Clonal and Subclonal TP53 Mutations in Chronic Lymphocytic Leukemia
    Bomben, Riccardo
    Rossi, Maria Francesca
    D'Agaro, Tiziana
    Bittolo, Tamara
    Zucchetto, Antonella
    Tissino, Erika
    Pozzo, Federico
    Vit, Filippo
    Bulian, Pietro
    Degan, Massimo
    Zaina, Eva
    Cattarossi, Ilaria
    Nanni, Paola
    Chivilo, Hillarj
    D'Arena, Giovanni Francesco
    Chiarenza, Annalisa
    Santinelli, Enrico
    Zaja, Francesco
    Pozzato, Gabriele
    Di Raimondo, Francesco
    Del Poeta, Giovanni
    Gattei, Valter
    BLOOD, 2018, 132
  • [10] Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia with TP53 Mutations
    Hwang, Steven R.
    Wang, Yucai
    Rabe, Kari G.
    He, Rong
    Kenderian, Saad S.
    Muchtar, Eli
    Hampel, Paul J.
    Kay, Neil E.
    Call, Timothy G.
    Koehler, Amber
    Behnken, Amy L.
    Leis, Jose F.
    Braggio, Esteban
    Shi, Min
    Viswanatha, David S.
    Van Dyke, Daniel L.
    Slager, Susan L.
    Parikh, Sameer A.
    Ding, Wei
    BLOOD, 2022, 140 : 12390 - 12392
12345